Sinclair Pharma PLC Holding(s) in Company (5498L)

TIDMSPH

RNS Number : 5498L

Sinclair Pharma PLC

03 October 2016

 
 For filings with the FCA 
  include the annex 
 For filings with issuer exclude 
  the annex 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
------------------------------------------------------------------------------------------------------ 
 
 1. Identity of the issuer or                                     Sinclair Pharma plc 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
---------------------------------------------------------------  ------------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
------------------------------------------------------------------------------------------------------ 
 An acquisition or disposal of voting rights 
------------------------------------------------------------------  ---------------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
------------------------------------------------------------------  ---------------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
------------------------------------------------------------------  ---------------------------------- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------------  ---------------------------------- 
 Other (please                                                                       x 
  specify): 
  Change to 
  notifiable 
  interest following 
  share issue. 
---------------------------------------------------------  -------  ---------------------------------- 
 3. Full name of person(s)                                    Abingworth LLP 
  subject to the                                               Abingworth Bioventures V LP 
  notification obligation:                                     Abingworth Bioequities Master 
  (iii)                                                        Fund Limited 
-----------------------------------------------------------  ----------------------------------------- 
 4. Full name of shareholder(s)                                        State Street (Nominees) Limited 
  (if different from 3.):(iv)                                               (as nominee for Abingworth 
                                                                                     Bioventures V LP) 
 
                                                                       Jefferies & Co Inc. (as nominee 
                                                                            for Abingworth Bioequities 
                                                                                  Master Fund Limited) 
-----------------------------------------------------------  ----------------------------------------- 
 5. Date of the transaction                                   30 September 2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-----------------------------------------------------------  ----------------------------------------- 
 6. Date on which issuer                                      3 October 2016 
  notified: 
-----------------------------------------------------------  ----------------------------------------- 
 7. Threshold(s) that is/are                                  Downward crossing of 6% threshold 
  crossed or                                                   - Abingworth LLP 
  reached: (vi, vii) 
-----------------------------------------------------------  ----------------------------------------- 
 
 
 
 8. Notified details: Abingworth LLP 
---------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
---------------------------------------------------------------------------------------------------------------------- 
 Class/type      Situation previous                  Resulting situation after the 
  of              to the triggering                   triggering transaction 
  shares          transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
--------------  ----------------------------------  ------------------------------------------------------------------ 
                 Number            Number            Number          Number of                % of voting 
                 of                 of                of shares       voting                   rights (x) 
                 Shares             Voting                            rights 
                                    Rights 
--------------  ----------------  ----------------  --------------  -----------------------  ------------------------- 
                                                     Direct          Direct     Indirect      Direct        Indirect 
                                                                     (xi)        (xii) 
--------------      ------------    ------------    --------------  ---------  ------------  ------------  ----------- 
 Sinclair 
  Pharma plc                       33,433,227                                   29,674,270                  5.91 
  GB0033856740 
  1p Ords 
                ----------------  ----------------  --------------  ---------  ------------  ------------  ----------- 
 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of financial   Expiration      Exercise/                         Number of voting           % of voting 
  instrument          date            Conversion                        rights that                rights 
                      (xiii)          Period (xiv)                      may be 
                                                                        acquired if 
                                                                        the 
                                                                        instrument 
                                                                        is 
                                                                        exercised/ 
                                                                        converted. 
------------------  --------------  --------------------------------  -------------------------  --------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of           Exercise        Expiration      Exercise/         Number of voting           % of voting 
 financial          price          date            Conversion         rights instrument          rights (xix, 
 instrument                        (xvii)          period             refers to                  xx) 
                                                   (xviii) 
----------------  --------------  --------------  ----------------  -------------------------  ----------------------- 
                                                                                                Nominal       Delta 
----------------  --------------  --------------  ----------------  -------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                               Percentage of voting rights 
----------------------------------------------------  ---------------------------------------------------------------- 
 29,674,270                                            5.91 
----------------------------------------------------  ---------------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
----------------------------------------------------------------------------- 
                          Abingworth Bioventures V LP (which holds 22,573,542 
                    shares in the company (4.50%)) and Abingworth Bioequities 
                         Master Fund Limited (which holds 7,100,728 shares in 
                          the company (1.41%)) are both managed by Abingworth 
                                                                         LLP. 
 
 Proxy Voting: 
----------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
-------------------------------------------------------------  -------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
-------------------------------------------------------------  -------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
-------------------------------------------------------------  -------------- 
 
 
  13. Additional information: 
-------------------------------------------------------------  -------------- 
 14. Contact name:                                              John Heard 
-------------------------------------------------------------  -------------- 
 15. Contact telephone number:                                  0207 534 1500 
-------------------------------------------------------------  -------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLMJBITMBAMBAF

(END) Dow Jones Newswires

October 03, 2016 10:56 ET (14:56 GMT)